Latest News about RHHBY
Recent news which mentions RHHBY
Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA
November 22, 2020
From Motley Fool
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
November 22, 2020
From Benzinga
5 Under-the-Radar Tickers That Will Stomp the Market in 2021
November 19, 2020
From Motley Fool
3 Best Biotech Stocks to Buy in November
November 18, 2020
From Motley Fool
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
From Benzinga
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
October 21, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
October 13, 2020
From Benzinga
IPO Outlook: Solar Power Company Array Technologies, Chinese Retailer Miniso Lead Possible 9 IPO Week
October 11, 2020
From Benzinga
After President Trump Gets Experimental Antibody Cocktail, Is Regeneron Stock a Good Coronavirus Buy?
October 10, 2020
From Motley Fool
Will Big Pharma Acquire Novavax?
October 03, 2020
From Motley Fool
Has Guardant Health Lived Up to the Hype?
September 29, 2020
From Motley Fool
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
September 26, 2020
From Benzinga
Better Coronavirus Stock: BioNTech or Vir Biotechnology?
September 26, 2020
From Motley Fool
If You Invested $10,000 in Guardant Health's IPO, This Is How Much Money You'd Have Today
September 26, 2020
From Motley Fool
Why Shares Of Small-Cap Biopharma AC Immune Are Plunging
September 23, 2020
From Benzinga
The Week Ahead In Biotech: Conference Presentations, IPOs In The Mix
September 20, 2020
From Benzinga
The Daily Biotech Pulse: Roche's COVID Combo Therapy Reduces Need For Ventilation, ESMO Presentations
September 18, 2020
From Benzinga
The Daily Biotech Pulse: Moderna Expands Into Switzerland, Tiziana To Spin Off Testing Unit, Metacrine IPO
September 16, 2020
From Benzinga
The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel's Regulatory Filing Accepted For Review
September 11, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial
September 10, 2020
From Benzinga
The Week Ahead In Biotech: Focus On Mallinckrodt FDA Decision, Conference Presentations
September 06, 2020
From Benzinga
The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study
September 04, 2020
From Benzinga
The Benefits Of Unsponsored ADRs
September 02, 2020
From Benzinga
Roche To Launch Rapid COVID-19 Test In Europe This Month, Seek FDA Emergency Use Approval
September 01, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.